Spots Global Cancer Trial Database for breast cancer
Every month we try and update this database with for breast cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer | NCT00075764 | Breast Cancer | anastrozole fulvestrant | 18 Years - | SWOG Cancer Research Network | |
| Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin | NCT02414269 | Malignant Pleur... Mesothelioma Metastases Lung Cancer Breast Cancer | iCasp9M28z T ce... cyclophosphamid... pembrolizumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 Years | NCT01480674 | Breast Cancer | Trastuzumab | 18 Years - | Hoffmann-La Roche | |
| Preoperative Localisation of the Sentinel Lymph Node in Breast Cancer | NCT01154972 | Breast Cancer | Preoperative se... | - | NHS Tayside | |
| Study of Health Effects of Cosmetic Breast Augmentation | NCT00342953 | Brain Cancer Breast Cancer Lung Cancer Suicide | 21 Years - 69 Years | National Institutes of Health Clinical Center (CC) | ||
| Circulating Tumor DNA to Monitor Response to Neoadjuvant Chemotherapy in Breast Cancer | NCT03260192 | Breast Cancer | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | ||
| Acquisition of Breast Mammography Images | NCT02156258 | Breast Cancer | FFDM Mammograph... DBT Mammography | 18 Years - | Fujifilm Medical Systems USA, Inc. | |
| Reflexology: An Intervention for Advanced Breast Cancer | NCT01577420 | Breast Cancer | Reflexology Ses... Placebo Session... | 21 Years - | Michigan State University | |
| Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery | NCT00381901 | Breast Cancer | trastuzumab polymorphism an... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Pyrotinib in Combination With Neoadjuvant Chemotherapy in HR+/HER2-, HER4 High Expression Breast Cancer Patients: A Phase II Trial | NCT04872985 | Breast Cancer Hormone-recepto... | Pyrotinib Epirubicin Doxorubicin Hyd... Cyclophosphamid... Docetaxel Nab paclitaxel Placebo | 18 Years - 75 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid | NCT00172029 | Breast Cancer W... | Zoledronic acid | 18 Years - | Novartis | |
| Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients | NCT04300790 | Breast Cancer | Alpelisib Metformin Fulvestrant Letrozole Exemestane Vildagliptin Tamoxifen | 18 Years - | MedSIR | |
| Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine | NCT00294385 | Breast Cancer | Docetaxel Gemcitabine, Do... Docetaxel | 18 Years - 75 Years | Central European Cooperative Oncology Group | |
| Evaluation of Safety and Performance of Intraoperative Detection of Light Signals During Electrosurgical Breast Cancer Resection | NCT06020573 | Breast Cancer Resection Margi... | Clip-on electro... | 18 Years - | Erbe Elektromedizin GmbH | |
| Stress Management Intervention Among Breast and Gynecologic Cancer Patients in Viet Nam | NCT06398067 | Breast Cancer Gynecologic Can... | Vietnamese Self... 'Doing What Mat... | 18 Years - | Boston University | |
| Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | NCT00667641 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu... | bortezomib paclitaxel | 18 Years - | Rutgers, The State University of New Jersey | |
| SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer | NCT00270413 | Metastatic Brea... | SU11248 | 18 Years - | Universitaire Ziekenhuizen KU Leuven | |
| An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast Cancer | NCT02286362 | Breast Cancer | 18 Years - | Hoffmann-La Roche | ||
| Study to Evaluate the Feasibility of 13-C Pyruvate Imaging in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy | NCT03121989 | Breast Cancer | Hyperpolarized ... Coil Testing NAC | 18 Years - 80 Years | Sunnybrook Health Sciences Centre | |
| Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer | NCT00238290 | Breast Cancer | Trastuzumab + L... | 18 Years - 120 Years | Swiss Group for Clinical Cancer Research | |
| Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation | NCT02729701 | Breast Cancer | Duavee | - 61 Years | University of Kansas Medical Center | |
| An Observational Study of Avastin (Bevacizumab) in Patients With HER2-metastatic or Locally Advanced Breast Cancer | NCT01461044 | Breast Cancer | 18 Years - | Hoffmann-La Roche | ||
| Patient Preference Survey for Radiation Oncologists | NCT00595218 | Breast Cancer Prostate Cancer Lung Cancer | Physician behav... Patient Prefere... | 18 Years - | University of Pittsburgh | |
| A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer | NCT00488722 | Breast Cancer | Zoladex | 25 Years - 50 Years | Tianjin Medical University | |
| Using AI to Select Women for Supplemental MRI in Breast Cancer Screening | NCT04832594 | Breast Cancer | AI selection fo... | 40 Years - 74 Years | Karolinska University Hospital | |
| S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer | NCT00068601 | Breast Cancer Infertility Menopausal Symp... | cyclophosphamid... goserelin aceta... | 18 Years - 49 Years | SWOG Cancer Research Network | |
| Cosmetic and Functional Outcomes After Breast Conserving Surgery | NCT01496001 | Breast Cancer | Lumpectomy, axi... Radiotherapy | - 70 Years | National Institute of Oncology, Hungary | |
| Decision Aids for Tamoxifen Treatment in Breast Cancer Patients | NCT02488603 | Breast Cancer | Decision aids (... tamoxifen | 18 Years - | National Cancer Center, Korea | |
| Comparison Study of Breast Computed Tomography (CT) With Magnetic Resonance Imaging (MRI) | NCT00957099 | Breast Cancer | 35 Years - | Emory University | ||
| Personalized Breast Cancer Screening | NCT06060938 | Breast Cancer | Risk stratified... Control arm | 50 Years - 67 Years | Herlev and Gentofte Hospital | |
| AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas | NCT03205176 | Malignant Solid... Lymphoma Ovarian Cancer Breast Cancer Pancreatic Canc... Prostate Cancer | AZD5153 Olaparib | 18 Years - 130 Years | AstraZeneca | |
| Role of Beta-Endorphin in Cancer Therapy Fatigue | NCT01113905 | Breast Cancer Fatigue | 18 Years - | Massachusetts General Hospital | ||
| Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study | NCT05019989 | Breast Cancer I... | Intervention gr... Control group: ... | 35 Years - 70 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Using Bupivacaine Locally in the Mastectomy Drains to Control Postoperative Pain | NCT03799757 | Pain, Postopera... Breast Cancer | 40ml of 0.25% b... 40ml of 0.9% no... | 30 Years - 65 Years | Alexandria University | |
| Exercise in Breast Cancer Survivors | NCT04307407 | Breast Cancer | Aerobic Exercis... | 28 Years - 72 Years | Norwegian School of Sport Sciences | |
| Consciousness-based Ayurveda Lifestyle Program for Improving Quality of Life in Survivors of Breast Cancer | NCT05743023 | Breast Cancer S... | Ayurvedic lifes... | 18 Years - | Maharishi International University | |
| Depocyt® With Sorafenib in Neoplastic Meningitis | NCT00964743 | Neoplastic Meni... | DepoCyt Sorafenib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors | NCT03712813 | Breast Cancer | Macrodyne LivMD... | 18 Years - | Indiana University | |
| Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients | NCT00516269 | Breast Cancer Fatigue Gastrointestina... | Methylphenidate Placebo | 18 Years - | M.D. Anderson Cancer Center | |
| A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH) | NCT06210776 | HER2-positive B... HER2-low Breast... Breast Cancer Advanced Cancer | Trastuzumab der... | 18 Years - | Daiichi Sankyo | |
| Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole | NCT00077168 | Breast Cancer | anastrozole tamoxifen citra... adjuvant therap... radiation thera... | 40 Years - 70 Years | National Cancer Institute (NCI) | |
| The PIONEER-01 Study of the Imagio Breast Imaging System | NCT01943916 | Breast Cancer | Imagio OA/US (U... Imagio gray sca... | 18 Years - | Seno Medical Instruments Inc. | |
| Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer | NCT00003016 | Breast Cancer | tamoxifen citra... adjuvant therap... | - | National Cancer Institute (NCI) | |
| Neratinib in Combination With Ruxolitinib in Patients With mTNBC | NCT06008275 | Metastatic Trip... Breast Cancer | Neratinib Oral ... Ruxolitinib Ora... | 18 Years - | Baylor Research Institute | |
| Reirradiation With Concurrent Paclitaxel for Breast Cancer | NCT02058667 | Breast Cancer | Paclitaxel+Init... | 18 Years - | University of Kentucky | |
| Vitamin D and Mammographic Breast Density | NCT01747720 | Breast Cancer | Vitamin D3 Placebo | 18 Years - 55 Years | CHU de Quebec-Universite Laval | |
| Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer | NCT00212095 | Metastatic Brea... | docetaxel and k... | 18 Years - | National University Hospital, Singapore | |
| A Biomarker Study in Patients With HER2-negative Metastatic Breast Cancer Treated With Bevacizumab and Paclitaxel | NCT01722968 | Breast Cancer | Bevacizumab Paclitaxel | 18 Years - 70 Years | Karolinska University Hospital | |
| A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer | NCT00246597 | Anemia Breast Neoplasm... Hemoglobins Quality of Life Chemotherapy, A... | epoetin alfa | 18 Years - | Ortho Biotech Products, L.P. | |
| Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer | NCT00003927 | Breast Cancer | filgrastim amifostine trih... cyclophosphamid... doxorubicin hyd... paclitaxel peripheral bloo... | 18 Years - 59 Years | City of Hope Medical Center | |
| Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential | NCT02621957 | Breast Cancer | GDC-0810 Pravastatin | 18 Years - 65 Years | Genentech, Inc. | |
| Breast Cancer Trials Education Program | NCT02808598 | Breast Cancer | Breast Cancer C... | 21 Years - | University of California, San Diego | |
| Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery | NCT02391194 | Breast Cancer | AVB-620 | 18 Years - | Avelas Biosciences, Inc. | |
| A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer | NCT00929240 | Breast Cancer | bevacizumab [Av... capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| Healing Touch During Chemotherapy Infusions for Women With Breast Cancer | NCT00533663 | Breast Cancer | Healing Touch Standard care guided relaxati... | 18 Years - 70 Years | Stanford University | |
| Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast | NCT00556907 | Breast Cancer | Intraoperative ... Intraoperative ... | 40 Years - | University of Southern California | |
| Brown Seaweed as a Breast Cancer Preventive | NCT01204957 | Breast Cancer | Seaweed and Soy... Placebo and Soy... | 18 Years - 80 Years | University of South Carolina | |
| Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer | NCT00416403 | Breast Cancer | fluvastatin sod... Breast Cancer S... | - | University of California, San Francisco | |
| Treatment of Hot Flushes in Breast Cancer Patients With Acupuncture | NCT00425776 | Breast Cancer Postmenopause | acupuncture Sham acupunctur... | 35 Years - | Vejle Hospital | |
| IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer | NCT00041223 | Breast Cancer Radiation Fibro... | IH636 grape see... | 18 Years - | National Cancer Institute (NCI) | |
| Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis | NCT04158843 | Breast Cancer Oligometastasis | Radical resecti... Radical radioth... Palliative trea... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Chemotherapy in Treating Patients With Breast Cancer | NCT00012129 | Breast Cancer | liposomal annam... | 18 Years - 120 Years | NYU Langone Health | |
| Targeted Pain Coping Skills Training (PCST) for Prevention and Treatment of Persistent Post-Mastectomy Pain | NCT02439437 | Breast Cancer | Psychosocial In... | 21 Years - 99 Years | Duke University | |
| Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer | NCT03204734 | Breast Cancer | Capecitabine endocrine thera... | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
| Clinical Application of Near-infrared Fluorescence Guided Localization on Breast Surgery in Breast Cancer | NCT02473159 | Breast Cancer | indocyanine gre... | 20 Years - 70 Years | National Cancer Center, Korea | |
| Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) | NCT00669747 | Ductal Carcinom... | Carboplatin i.d... Carboplatin i.d... Normal Saline | 18 Years - | Windy Hill Medical, Inc. | |
| Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer | NCT03936478 | Breast Cancer DCIS LCIS | MRIdian Radiati... | 40 Years - | University of Wisconsin, Madison | |
| Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction | NCT04016376 | Breast Cancer Breast Cancer F... | PVB Protocol PECS-1 Serratus | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself. | NCT06086340 | Breast Cancer | Palbociclib Aromatase Inhib... | 65 Years - | Pfizer | |
| Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2α and LTC4 Levels | NCT01811199 | Thyroid Cancer Breast Cancer | 18 Years - 65 Years | Marmara University | ||
| Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk | NCT00735150 | Breast Cancer Ovarian Cancer | questionnaire, ... | 18 Years - 39 Years | Memorial Sloan Kettering Cancer Center | |
| A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients | NCT01764022 | Human Epithelia... | Trastuzumab Paclitaxel | 18 Years - 75 Years | Biocad | |
| Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO) | NCT01160094 | Cancer | Treatment | 18 Years - | Novartis | |
| Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation | NCT02664389 | Breast Cancer Ovarian Cancer Colorectal Canc... Pediatric Cance... Multiple Primar... | Genetic analysi... | - | University Hospital, Rouen | |
| A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6 | NCT00900744 | Breast Cancer | Tamoxifen | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Effect of Lifestyle Factors and Hormone Function on Breast Density in Healthy Hispanic Women Who Are Undergoing Mammography for Breast Cancer Screening | NCT00131950 | Breast Cancer | physiologic tes... study of socioe... breast imaging ... study of high r... | 40 Years - | National Cancer Institute (NCI) | |
| Supervised Resistance TRaining amONG Women at Risk of Breast Cancer Related Lymphedema | NCT04821609 | Breast Cancer Physical Activi... Lymphedema of U... | Resistance Trai... | 18 Years - 70 Years | Pontificia Universidad Catolica de Chile | |
| Adaptation of a Knowledges Exchange Portal Between (KEP) Healers and Patients : Obstacles and Sources to KEP Use for Breast Cancer Women | NCT03472794 | Breast Cancer | web portal: " M... | 18 Years - | University Hospital, Bordeaux | |
| Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors | NCT03911453 | Breast Cancer | Rucaparib | 21 Years - | University of Arizona | |
| Skeletal Events of Hormonal Treatment and Radiotherapy in Patient With Breast Cacer | NCT04792840 | Breast Cancer | Femara Pill | 40 Years - 70 Years | Assiut University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
